News
News from us and our partners
Tags
Topics
0 results
- News
Inventiva prices $150M ADS public offering for MASH program
- News
Qorium secures €22M to scale cultivated leather production
- News
Muna Therapeutics doses first patients with TREM2 agonist MNA-001
- News
Noema Pharma reports Phase 2a data for cendifensine in menopause
- News
Tulyp Medical emerges from stealth and files FDA 510(k)
- News
Abivax reports Phase 3 PRO data for obefazimod in UC
- News
AAVantgarde in $141M Series B for retinal disease programs
- News
Hemab Therapeutics raises $157M Series C for bleeding disorders
- News
Elevara Medicines raises $70M Series A for RA Phase 2 trial
- News
Mission Therapeutics raises $13.3M to advance MTX325 in Parkinson's
- News
Verley gets FDA no-questions letter for fermentation proteins
- News
NanoPhoria raises €83.5M Series A for HFrEF therapy
- News
AAVantgarde wins FDA orphan drug designation
- News
Sitryx receives FDA IND clearance for SYX-5219 in atopic dermatitis
- News
Inventiva appoints Andrew Obenshain as CEO